Global Finance News
18 Feb 2026, 23:27
Kenvue Inc. (NYSE: KVUE) reported improved fourth-quarter performance but lower full-year sales for 2025.
Fourth-quarter net sales rose 3.2%, driven by 1.2% organic growth and a 2.1% FX benefit. Diluted EPS was $0.17, with adjusted EPS of $0.27. Gross margin was flat at 56.5%, while adjusted operating margin improved to 19.9%. Growth was led by Essential Health (+6.1%) and Skin Health and Beauty (+2.9%), while Self Care rose 1.5%.
For full-year 2025, net sales declined 2.1%, with organic sales down 2.2% due to lower volumes. Diluted EPS was $0.76 and adjusted EPS was $1.08. Free cash flow increased to $1.7 billion, and total debt stood at $8.5 billion at year-end.
Due to its pending merger with Kimberly-Clark, expected to close in the second half of 2026, Kenvue will not provide forward guidance.
Source: Business Wire
Fourth-quarter net sales rose 3.2%, driven by 1.2% organic growth and a 2.1% FX benefit. Diluted EPS was $0.17, with adjusted EPS of $0.27. Gross margin was flat at 56.5%, while adjusted operating margin improved to 19.9%. Growth was led by Essential Health (+6.1%) and Skin Health and Beauty (+2.9%), while Self Care rose 1.5%.
For full-year 2025, net sales declined 2.1%, with organic sales down 2.2% due to lower volumes. Diluted EPS was $0.76 and adjusted EPS was $1.08. Free cash flow increased to $1.7 billion, and total debt stood at $8.5 billion at year-end.
Due to its pending merger with Kimberly-Clark, expected to close in the second half of 2026, Kenvue will not provide forward guidance.
Source: Business Wire